AAAAAA

   
Results: 1-12 |
Results: 12

Authors: ALJEHANI RM JEYARAJAH AR HAGEN B HOGDALL EV ORAM DH JACOBS IJ
Citation: Rm. Aljehani et al., MODEL FOR THE MOLECULAR-GENETIC DIAGNOSIS OF ENDOMETRIAL CANCER USINGK-RAS MUTATION ANALYSIS, Journal of the National Cancer Institute, 90(7), 1998, pp. 540-542

Authors: ROSENTHAL AN RYAN A ALJEHANI RM STOREY A HARWOOD CA JACOBS IJ
Citation: An. Rosenthal et al., P53 CODON-72 POLYMORPHISM AND RISK OF CERVICAL-CANCER IN UK, Lancet, 352(9131), 1998, pp. 871-872

Authors: RYAN A ALJEHANI RM MULLIGAN KT JACOBS IJ
Citation: A. Ryan et al., NO EVIDENCE EXISTS FOR METHYLATION INACTIVATION OF THE P16 TUMOR-SUPPRESSOR GENE IN OVARIAN CARCINOGENESIS, Gynecologic oncology, 68(1), 1998, pp. 14-17

Authors: WOOLAS RP ORAM DH BROWN CL JACOBS IJ
Citation: Rp. Woolas et al., PRIMARY-CARCINOMA OF THE PELVIC PERITONEUM INTERCEPTED BY SCREENING FOR OVARIAN-CANCER, International journal of gynecological cancer, 7(3), 1997, pp. 245-247

Authors: WOOLAS RP ORAM DH PRYSDAVIES A LEAKE J BROWN CL JACOBS IJ
Citation: Rp. Woolas et al., CA125 EXPRESSION AT CLINICAL-DIAGNOSIS BY OVARIAN-CARCINOMA NOT DETECTED THROUGH ANTECEDENT SERUM CA125 SCREENING, International journal of gynecological cancer, 6(2), 1996, pp. 98-101

Authors: JACOBS IJ SKATES S DAVIES AP WOOLAS RP JEYERAJAH A WEIDEMANN P SIBLEY K ORAM DH
Citation: Ij. Jacobs et al., RISK OF DIAGNOSIS OF OVARIAN-CANCER AFTER RAISED SERUM CA-125 CONCENTRATION - A PROSPECTIVE COHORT STUDY, BMJ. British medical journal, 313(7069), 1996, pp. 1355-1358

Authors: SKATES SJ JACOBS IJ SJOVALL K EINHORN N XU FJ YU YH BAST RC KNAPP RC
Citation: Sj. Skates et al., HIGH-SENSITIVITY AND SPECIFICITY OF SCREENING FOR OVARIAN-CANCER WITHTHE RISK OF OVARIAN-CANCER (ROC) ALGORITHM-BASED ON RISING CA125 LEVELS, Journal of clinical oncology, 14(5), 1996, pp. 2007-2007

Authors: WOOLAS RP CONAWAY MR XU FJ JACOBS IJ YU YH DALY L DAVIES AP OBRIANT K BERCHUCK A SOPER JT CLARKEPEARSON DL RODRIGUEZ G ORAM DH BAST RC
Citation: Rp. Woolas et al., COMBINATIONS OF MULTIPLE SERUM MARKERS ARE SUPERIOR TO INDIVIDUAL ASSAYS FOR DISCRIMINATING MALIGNANT FROM BENIGN PELVIC MASSES, Gynecologic oncology, 59(1), 1995, pp. 111-116

Authors: HURTEAU JA WOOLAS RP JACOBS IJ ORAM DC KURMAN CC RUBIN LA NELSON DL BERCHUCK A BAST RC MILLS GB
Citation: Ja. Hurteau et al., SOLUBLE INTERLEUKIN-2 RECEPTOR-ALPHA IS ELEVATED IN SERA OF PATIENTS WITH BENIGN OVARIAN NEOPLASMS AND EPITHELIAL OVARIAN-CANCER, Cancer, 76(9), 1995, pp. 1615-1620

Authors: WOOLAS RP XU FJ JACOBS IJ YU YH DALY L BERCHUCK A SOPER JT CLARKEPEARSON DL ORAM DH BAST RC
Citation: Rp. Woolas et al., ELEVATION OF MULTIPLE SERUM MARKERS IN PATIENTS WITH STATE-I OVARIAN-CANCER, Journal of the National Cancer Institute, 85(21), 1993, pp. 1748-1751

Authors: KOHLER MF MARKS JR WISEMAN RW JACOBS IJ DAVIDOFF AM CLARKEPEARSON DL SOPER JT BAST RC BERCHUCK A
Citation: Mf. Kohler et al., SPECTRUM OF MUTATION AND FREQUENCY OF ALLELIC DELETION OF THE P53 GENE IN OVARIAN-CANCER, Journal of the National Cancer Institute, 85(18), 1993, pp. 1513-1519

Authors: JACOBS IJ RIVERA H ORAM DH BAST RC
Citation: Ij. Jacobs et al., DIFFERENTIAL-DIAGNOSIS OF OVARIAN-CANCER WITH TUMOR-MARKERS CA 125, CA 15-3 AND TAG 72-CENTER-DOT-3, British journal of obstetrics and gynaecology, 100(12), 1993, pp. 1120-1124
Risultati: 1-12 |